iBio, Inc. — Director's Dealing 2010

Dec 21, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBPM.OB)
CIK: 0001420720
Period of Report: 2009-01-21

Reporting Person: DESANTIS CARL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-01-21	Common Stock	P	35778	$0.29	Acquired	5551419	Indirect
2009-01-21	Common Stock	P	28000	$0.29	Acquired	5551419	Indirect
2010-10-27	Common Stock	P	250000	$2.00	Acquired	5551419	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-27	Warrant to Purchase Common Stock	$2.20	P	250000	Acquired	2015-10-27	Common Stock (250000)	Indirect

Footnotes

F1: Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc., of which the reporting person is a controlling person, (iii) 1,719,393 shares of common stock held by CD Financial, LLC, (iv) 250,000 shares of common stock issuable upon exercise of a warrant held by CD Financial, LLC, and (v) 2,245,417 shares of common stock held by the DeSantis Revocable Trust.

F2: Warrant issued together with shares of common stock sold at a purchase price of $2.00 per share.